LVZ Inc’s Allena Pharmaceuticals ALNA Stock Holding History

LVZ Inc’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,735	Closed	-$66K	–	92
2019 Q3	$66K	Buy	+16,735	New	+$71.8K	0.01%	77

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return

LVZ Inc's ALNA Position: Q4 2019 in Review

LVZ Inc sold out of Allena Pharmaceuticals (ALNA) in Q4 2019, closing a stake of 16,735 shares — an estimated $66K sold.

LVZ Inc first reported a position in ALNA in Q3 2019 and held it in 1 quarter. The position peaked at $66K in Q3 2019. 26 funds tracked by Wall St. Rank hold ALNA as of Q4 2019.

LVZ Inc reported no remaining Allena Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
LVZ Inc sold 16,735 Allena Pharmaceuticals shares in Q4 2019, an estimated $66K.
LVZ Inc first reported a position in Allena Pharmaceuticals in Q3 2019 and held it in 1 quarter.
LVZ Inc's Allena Pharmaceuticals position peaked at $66K in Q3 2019.
26 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2019.

Based on LVZ Inc's 13F filing for Q4 2019, filed 5 Feb 2020.